Medicrea Growth Driven by U.S. Sales of Patient-Specific Implants

Medicrea reported 3Q19 revenue of €8.2million (USD $9.2 million), +12.3% vs. 3Q18.

Growth was driven by strength in key markets like the U.S. (+17.8%) and Belgium (+15%)
In 3Q19, 500 surgeries were performed with Medicrea patient-specific implants, representing a 57% increase overall vs. the prior year (+77% in the U.S.)

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us